https://www.selleckchem.com/Bcl-2.html
4 ± 56.0 vs. 9.3 ± 21.0; p 0.01). Platelet function testing does not provide orientation concerning stroke mechanism in patients who were previously on APDs. However, the high frequency of APD resistance and its association with inflammation and stroke severity are confirmed. Platelet function testing does not provide orientation concerning stroke mechanism in patients who were previously on APDs. However, the high frequency of APD resistance and its association with inflammation and stroke severity are confirmed.The structural properties and